Skip to Main Content

Author Details

Nadine Czudnochowski
University of California san francisco
2005
32
20
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36711984Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.bioRxiv2023
37613467How a Potent Anti-neuraminidase Monoclonal Antibody Navigates Recent Immune-evasive Influenza Strains: A Structural Study by Single-particle CryoEM.Microsc Microanal2023
37258672A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.Nature2023
37407829Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.Nature2023
35143540Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.PLoS One2022
35730550Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries.Glob Health Action2022
35857529Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.Science2022
36203553Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.bioRxiv2022
35076256Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.Science2022
35016195Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.Nature2022
34280951Broad sarbecovirus neutralization by a human monoclonal antibody.Nature2021
33851169Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.bioRxiv2021
33851154Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape.bioRxiv2021
33621484Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.Cell2021
34931194Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.bioRxiv2021
34344823Broad betacoronavirus neutralization by a stem helix-specific human antibody.Science2021
34261126SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.Nature2021
32991844Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.Cell2020
32972994Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.Science2020
31239378Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.mBio2019
31886769The structure of the endogenous ESX-3 secretion system.Elife2019
28252385<i>Chlamydia</i> interfere with an interaction between the mannose-6-phosphate receptor and sorting nexins to counteract host restriction.Elife2017
26470919Crystal Structure of the Human tRNA m(1)A58 Methyltransferase-tRNA(3)(Lys) Complex: Refolding of Substrate tRNA Allows Access to the Methylation Target.J Mol Biol2015
24214967The mechanism of pseudouridine synthases from a covalent complex with RNA, and alternate specificity for U2605 versus U2604 between close homologs.Nucleic Acids Res2014
23707380In human pseudouridine synthase 1 (hPus1), a C-terminal helical insert blocks tRNA from binding in the same orientation as in the Pus1 bacterial homologue TruA, consistent with their different target selectivities.J Mol Biol2013
22588304Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition.Nat Commun2012
20385237Formation of Tat-TAR containing ribonucleoprotein complexes for biochemical and structural analyses.Methods2011
21819963Mechanistic insights into the translocation of full length HIV-1 Tat across lipid membranes.Biochim Biophys Acta2011
19883659Specificity of Hexim1 and Hexim2 complex formation with cyclin T1/T2, importin alpha and 7SK snRNA.J Mol Biol2010
17341462Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.Nucleic Acids Res2007
16754675Structure of the hemolysin E (HlyE, ClyA, and SheA) channel in its membrane-bound form.J Biol Chem2006
15855166Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat.J Biol Chem2005
  • 1 - 32 of 32

Recommended Authors

Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 6
Taha Y Taha
Gladstone Institutes
Career Start Year 2015
Number of shared co-authors 2
Yushen Du
University of California los angeles
Career Start Year 2014
Number of shared co-authors 3
Soumya G Remesh
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2014
Number of shared co-authors 5
Markus-Frederik Bohn
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2012
Number of shared co-authors 4
Sergei Pourmal
University of California san francisco
Career Start Year 2010
Number of shared co-authors 7
Jennifer M Binning
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2010
Number of shared co-authors 3
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 5
Connie Chen
University of California davis
Career Start Year 2009
Number of shared co-authors 0
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 7
Rick K Huang
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
James B Munro
University of Massachusetts Chan Medical School
Career Start Year 2004
Number of shared co-authors 0
Felipe Diaz-Griffero
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Brian P Hudson
The State University of New Jersey
Career Start Year 2000
Number of shared co-authors 0
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 4
Daisy W Leung
Washington University School of Medicine
Career Start Year 1999
Number of shared co-authors 4
Teit Max Moscote S??gaard
Expres2ion Biotechnologies
Career Start Year 1998
Number of shared co-authors 1
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 2
Zihe Rao
Nankai University
Career Start Year 1995
Number of shared co-authors 0
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 3
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 1
Melanie Ott
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 11
Steven C Almo
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 1
Raymond J Owens
University of Oxford
Career Start Year 1986
Number of shared co-authors 0
Ursula Schulze-Gahmen
Gladstone Institute of Virology, Gladstone Institutes San Francisco CA USA .
Career Start Year 1985
Number of shared co-authors 8
Wesley I Sundquist
University of Utah School of Medicine
Career Start Year 1982
Number of shared co-authors 2
Stephen K Burley
The State University of New Jersey
Career Start Year 1982
Number of shared co-authors 0
David I Stuart
University of Oxford
Career Start Year 1976
Number of shared co-authors 2
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 2

Collaborators

David Veesler
Co-authored papers 13
Amalio Telenti
Vir Biotechnology Inc.
Co-authored papers 12
Alexandra C Walls
Co-authored papers 10
Roberto Spreafico
Co-authored papers 4
Jason A Wojcechowskyj
Gladstone Institutes
Co-authored papers 4
Oren S Rosenberg
University of California san francisco
Co-authored papers 4
Michael S Diamond
Washington University School of Medicine
Co-authored papers 4
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 3
Robert M Stroud
University of California San Francisco
Co-authored papers 3
Nisar Farhat
University of California los angeles
Co-authored papers 3
Janet Finer-Moore
University of California San Francisco
Co-authored papers 3
Julia Noack
University of California san francisco
Co-authored papers 2
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 2
Laura A VanBlargan
Washington University School of Medicine
Co-authored papers 2
Rachel Nakagawa
University of California san francisco
Co-authored papers 2
Michael C Maher
Vir Biotechnology Inc.
Co-authored papers 2
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 2
Joseph D O'Connell
Department of Pharmaceutical Chemistry, University of California-San Francisco
Co-authored papers 1
Michael Rape
Howard Hughes Medical Institute, University of California at Berkeley
Co-authored papers 1
Lucy M Li
Co-authored papers 1
Ivan Mwebaza
Case Western Reserve University School of Medicine
Co-authored papers 1
Stephen L Isaacs
Robert Wood Johnson Foundation in Princeton
Co-authored papers 1
Katie A Lien
Pritzker School of Medicine, University of Chicago
Co-authored papers 1
Manu Vanaerschot
Columbia University Irving Medical Center
Co-authored papers 1
Jeremy M Rock
The Rockefeller University
Co-authored papers 1
Eric Lee
School of Public Health, University of California berkeley
Co-authored papers 1
Michael S Glickman
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 1
Matt Knight
University of California berkeley
Co-authored papers 1
Isabelle Charles
Co-authored papers 1
Release 1.2